PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence
- Alexander Mm Eggermont
- , Paolo A. Ascierto
- , Nikhil I. Khushalani
- , Dirk Schadendorf
- , Genevieve Boland
- , Jeffrey Weber
- , Karl D. Lewis
- , Daniel Johnson
- , Gareth Rivalland
- , Adnan Khattak
- , Margarita Majem
- , Helen Gogas
- , Georgina V. Long
- , Sue L. Currie
- , David Chien
- , Mary A. Tagliaferri
- , Matteo S. Carlino
- , Adi Diab
Research output: Contribution to journal › Article › peer-review
9
Link opens in a new tab
Scopus
citations